Curbside Consultation in Glaucoma : 49 Clinical Questions.
Material type:
- text
- computer
- online resource
- 9781040141359
- 617.7/41
- RE871 .C872015
Cover -- Half Title -- Title Page -- Copyright Page -- Dedication -- Table of Contents -- Acknowledgments -- About the Editor -- About the Associate Editors -- Contributing Authors -- Preface -- Section I General Principles -- Question 1 How Frequently Does Blindness Develop Among Patients With Primary Open-Angle Glaucoma? With Ocular Hypertension? -- Question 2 Does Reducing Intraocular Pressure Really Prevent the Development and Progression of Glaucoma? -- Question 3 Are Vascular Factors Involved in the Pathogenesis of Glaucoma? -- Question 4 What Are the Most Frequent Causes of Glaucoma-Related Medical Malpractice Suits? What Can I Do to Minimize My Risk? -- Question 5 How Does Glaucoma Affect Quality of Life? Why Does It Matter? -- Section II Glaucoma Diagnosis -- Question 6 How Should I Clinically Examine the Optic Nerve? -- Question 7 What Imaging Technology Is Best for Diagnosing Glaucoma? For Detecting Progression? -- Question 8 What Visual Field Tests Should I Use? How Should I Judge Progression? -- Question 9 What Are the Implications of Disc Hemorrhages in Glaucoma Patients or Suspects? -- Question 10 How Should I Follow Patients With Anomalous Optic Discs, Such as Those With Optic Nerve Drusen, Tilted Discs, Myopic Discs, and Discs With Pits? -- Question 11 How Frequently Should I Perform Follow-up Examinations, Gonioscopy, Visual Field Testing, and Optic Nerve Evaluation in Patients With Glaucoma? -- Question 12 Should I Mea sure Central Corneal Thickness in All Patients With Glaucoma? All Glaucoma Suspects? -- Question 13 What New Methods Are Available to Mea sure Intraocular Pressure? Are Any Devices Available for Continuous Monitoring of Intraocular Pressure? -- Question 14 When Is Imaging of the Anterior Segment Useful?.
Question 15 In Which Patients With Glaucoma Should I Perform Neuroimaging, Cardiovascular Evaluation, and/or Laboratory Testing? -- Question 16 Is Genetic Testing Useful in Screening in Glaucoma? -- Question 17 How Is Cerebrospinal Fluid Pressure Related to Glaucoma? -- Question 18 Do Anti-Vascular Endothelial Growth Factor Injections Cause Intraocular Pressure Elevation? -- Question 19 What Is the Best Way to Classify Angle Closure Glaucomas? -- Section III General Management -- Question 20 Which Patients With Ocular Hypertension Should I Treat? -- Question 21 How Should I Set a Target Intraocular Pressure? -- Question 22 How Should I Begin Treatment for a Patient With Newly Diagnosed Primary Open-Angle Glaucoma? -- Question 23 How Should I Manage a Patient Who Is Progressing at Low Levels of Intraocular Pressure? -- Question 24 Are There Special Issues of Which I Should Be Aware Regarding Pigment Dispersion Syndrome or Pigmentary Glaucoma? -- Question 25 Does Exfoliation Syndrome Increase the Risk of Developing Glaucoma? Are Patients With Exfoliation Glaucoma More Likely to Progress? What Other Issues Do These Patients Have? -- Question 26 How Frequent Is Corticosteroid-Induced Glaucoma? How Should I Manage It? -- Question 27 What Methods Are Available to Break an Acute Attack of Angle Closure Glaucoma? -- Question 28 How Should I Manage Neovascular Glaucoma? -- Question 29 How Should I Treat Elevated Intraocular Pressure (With or Without Glaucoma Damage) Associated With Uveitis? -- Question 30 How Should Children With Congenital Glaucoma Be Followed? -- Section IV Medical Therapy -- Question 31 Are Any New Medications in Development? Are Any Neuroprotective Agents Currently Available for Treating Glaucoma? -- Question 32 Which Glaucoma Medications Can Be Safely Used During Pregnancy? In Childhood?.
Question 33 Is There Still a Role for Miotics in Some Patients? Oral Carbonic Anhydrase Inhibitors? -- Question 34 How Can I Improve Patient Adherence? -- Section V Laser and Incisional Glaucoma Surgery -- Question 35 Is Selective Laser Trabeculoplasty a Repeatable Procedure? When Should I Use It? -- Question 36 When Should I Perform a Prophylactic Laser Iridotomy? -- Question 37 When Is Laser Iridoplasty Used? -- Question 38 When Should I Perform Incisional Glaucoma Surgery? Which Procedure Should I Choose? -- Question 39 Are Anti-Vascular Endothelial Growth Factor Agents Useful Adjuncts to Glaucoma Filtering Surgery? -- Question 40 What Are Surgical Pearls for Performing Trabeculectomy? -- Question 41 What Are Pearls for the Postoperative Management of Trabeculectomy and Its Associated Complications? -- Question 42 What Are Surgical Pearls for Performing Aqueous Shunt Implantation? -- Question 43 What Are Pearls for Postoperative Management of Aqueous Shunt Implantation and Its Associated Complications? -- Question 44 Which Aqueous Shunt Should I Use? -- Question 45 Does Cataract Extraction Produce a Significant and Sustained Intraocular Pressure Reduction? When Should I Perform a Combined Procedure vs Cataract Extraction Alone? -- Question 46 Is Cataract Surgery a Useful Treatment for Angle Closure Glaucoma? -- Question 47 Does the Presence of Glaucoma Influence Your Choice of Intraocular Lens Implant? -- Question 48 In Which Glaucoma Patients Should I Consider Cyclodestruction? -- Question 49 What Are MIGS? When Should I Use Them? -- Financial Disclosures -- Index.
Curbside Consultation in Glaucoma, Second Edition contains new questions and brief, practical, evidence-based answers to the most frequently asked questions that are posed during a "curbside consultation" between surgical colleagues.
Description based on publisher supplied metadata and other sources.
Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
There are no comments on this title.